Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Poulam M. Patel
Based on 17 articles published since 2010
(Why 17 articles?)
||||
Expertise Level
The expertise of Poulam M. Patel ranks in the
  • Top 0.73%
  • ... of 120,378 published authors worldwide on Melanoma
  • ... from 2010 through 2020
  • ... based on contributions to 17 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Patel, Poulam M   ·   Patel, Poulam   ·   Patel, P M
Work Locations
Details
Most likely:    University of Nottingham      
2019
  • Department of Medical Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge. · AstraZeneca UK, Clinical Discovery Unit, Early Clinical Development, IMED Biotech Unit, Melbourn, UK. · Department of Biostatistics, University Health Network, Toronto, Canada. · EORTC Headquarters, Brussels, Belgium. · Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Charité-Universitätsmedizin, Berlin. · Department of Dermatology, University Hospital, University Duisburg-Essen, Germany & German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · Ocular Oncology Service, Department of Ophthalmology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland. · Department of Dermatology, Saarland University Medical School, Hamburg, Germany. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, USA. · Department of Diagnostic and Interventional Radiology, Darmstadt, Germany. · Department of Medical Oncology, Maastricht University Medical Centre, Maastricht. · Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands. · Centre Oscar Lambret, Lille, France. · Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Johann Wolfgang Goethe-University, Frankfurt, Germany. · Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada. · Oncology Unit, Azienda Ospedaliera 'Ospedali Riuniti Marche Nord', Pesaro, Italy. · University of Rennes, INSERM, Department of Ophthalmology, CHU Rennes, Rennes, France. · UPMC Hillman Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, USA. · Academic Unit of Oncology, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK. · Division of Hematology/Oncology, Columbia University Medical Center, New York, USA. · Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney. · Melanoma Institute of Australia, Sydney, Australia. · Pubmed 31150059
2018
  • Academic Department of Clinical Oncology, Division of Cancer & Stem Cells, University of Nottingham, Nottingham, UK. · Southampton Experimental Cancer Medicine Centre and Southampton University Hospitals, Faculty of Medicine, Southampton, UK. · St James's University Hospital, Leeds, UK. · Institute of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Northern Institute for Cancer Research, Medical School, University of Newcastle-upon-Tyne and Wear, UK. · Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, UK. · University of Nottingham, School of Medicine Queen's Medical Centre, Nottingham, UK. · Scancell Limited, Academic Department of Clinical Oncology, University of Nottingham, Nottingham, UK. · Ichor Medical Systems, Inc., San Diego, CA, USA. · Pubmed 29872563
2015
  • Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · National Heart and Lung Institute, Imperial College, London, UK. · Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK. · Department of Pathology, University Hospitals Leuven, Leuven, Belgium. · European Organisation for Research and Treatment of Cancer (EORTC) Melanoma Group, Brussels, Belgium. · Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · School of Medicine, University of Nottingham, Nottingham, UK. · Department of Dermatology, Essen University Hospital, Essen, and German Consortium of Translational Cancer Research (DKTK), Heidelberg, Germany. · Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. · Pubmed 25871393
2014
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
2013
  • Alexander M.M. Eggermont, Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, and Université Paris-Sud, Kremlin Bicêtre, Paris, France · Stefan Suciu, Larissa Polders, and Michel Praet, European Organisation for Research and Treatment of Cancer, Brussels, Belgium · Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland · Jeremy Marsden, University Hospital Birmingham, Birmingham · Philippa Corrie, Addenbrookes Hospital, Cambridge · Poulam M. Patel, University of Nottingham, Nottingham · Neville Davidson, Broomfield Hospital, Broomfield, United Kingdom · Mario Santinami, Istituto Nazionale dei Tumori, Milan · Paolo A. Ascierto, Istituto Nazionale Tumori Fondazione Pascale, Napoli · Lorenzo Borgognoni, Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence · Maria Grazia Bernengo, University Hospital Turin, Turin, Italy · Steinar Aamdal, Oslo University Hospital and Radium Hospital, Oslo, Norway · Wim H. Kruit, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands · Lars Bastholt, Odense University Hospital, Odense, Denmark · and Alan Spatz, McGill University and Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Pubmed 24019551
2011
  • Academic Unit of Clinical Oncology, University of Nottingham, Nottingham, United Kingdom. · Pubmed 21600759
2014
  • Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, UK. · Pubmed 24830350
2012
  • Academic Oncology, School of Molecular Medical Sciences, University of Nottingham , Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom. · Pubmed 23215743
  • Academic Oncology, University of Nottingham, School of Molecular Medical Sciences, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, UK. · Pubmed 22080065
2011
  • Translational DNA Repair Group, Laboratory of Molecular Oncology, Academic Unit of Oncology, School of Molecular Medical Sciences, Nottingham University Hospitals, University of Nottingham, Nottingham, UK. · Pubmed 21266972
Probable:    Nottingham University Hospitals NHS Trust      
2018
  • Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Medical Oncology, Mount Vernon Hospital, Northwood, UK. · Department of Medical Oncology, Christie Hospital, Manchester, UK. · Royal Marsden Hospital NHS Trust, London, UK. · Oncology Research, Broomfield Hospital, Chelmsford, UK. · Oncology Department, Leicester Royal Infirmary, Leicester, UK. · Sir Bobby Robson Cancer Trials Research Centre, Freeman Hospital, Newcastle upon Tyne, UK. · Leeds Cancer Centre, St James's University Hospital, Leeds, UK. · Weston Park Hospital, Academic Unit of Clinical Oncology, Sheffield, UK. · Cancer & Palliative Care, St. Helen's Hospital, St. Helens, UK. · Oncology Department, Royal Surrey County Hospital, Guildford, UK. · Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Clinical Trials Unit, Beatson WOS Cancer Centre, Glasgow, UK. · Department of Clinical Oncology, Norfolk & Norwich University Hospital, Norwich, UK. · Guy's & St. Thomas' Hospital, Guy's Cancer Centre, London, UK. · Velindre Cancer Centre, Cardiff, UK. · Exeter Oncology Centre, Royal Devon and Exeter Hospital, Exeter, UK. · St George's Hospital, Cancer Centre, London, UK. · Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK. · Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, UK. · Cancer Centre, Ninewells Hospital, Dundee, UK. · Royal Free Hospital, London, UK. · Castle Hill Hospital, Cottingham, UK. · Academic Unit of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK. · CRUK and NIHR Southampton Experimental Cancer Medicine Centre, Southampton University Hospitals NHS Foundation Trust, Southampton, UK. · Oncology Centre, Cheltenham General Hospital, Cheltenham, UK. · Oncology Department, James Cook University Hospital, Middlesbrough, UK. · Oncology Department, Poole Hospital, Dorset, UK. · Department of Oncology, University of Oxford, Oxford, UK. · Experimental Cancer Medicine Centre, Oxford, UK. · Melanoma Focus, Cambridge, UK. · Oxford NIHR Biomedical Research Centre, Oxford, UK. · Pubmed 30010756
2014
  • Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, UK. · Pubmed 24830350
2012
  • Academic Oncology, School of Molecular Medical Sciences, University of Nottingham , Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom. · Pubmed 23215743
  • Academic Oncology, University of Nottingham, School of Molecular Medical Sciences, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, UK. · Pubmed 22080065
2011
  • Translational DNA Repair Group, Laboratory of Molecular Oncology, Academic Unit of Oncology, School of Molecular Medical Sciences, Nottingham University Hospitals, University of Nottingham, Nottingham, UK. · Pubmed 21266972
Probable:    Miscellaneous institutions in Brussels      
2015
  • Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · National Heart and Lung Institute, Imperial College, London, UK. · Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK. · Department of Pathology, University Hospitals Leuven, Leuven, Belgium. · European Organisation for Research and Treatment of Cancer (EORTC) Melanoma Group, Brussels, Belgium. · Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · School of Medicine, University of Nottingham, Nottingham, UK. · Department of Dermatology, Essen University Hospital, Essen, and German Consortium of Translational Cancer Research (DKTK), Heidelberg, Germany. · Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. · Pubmed 25871393
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 17 total) written by Poulam M. Patel about Melanoma:

  • Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study. 2019
  • Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial. 2018
  • Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial. 2018
  • Biology of advanced uveal melanoma and next steps for clinical therapeutics. 2015
  • Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort. 2015
  • Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy. 2014
  • Inherited variation in the PARP1 gene and survival from melanoma. 2014
  • Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials. 2014
  • Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial. 2013
  • Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials. 2013
Show List of Full Article Records
Google Searches

Learn more about Poulam M. Patel using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Nottingham
Nottingham University Hospitals NHS Trust
Miscellaneous institutions in Brussels
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Nottingham
2019
  • Department of Medical Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge. · AstraZeneca UK, Clinical Discovery Unit, Early Clinical Development, IMED Biotech Unit, Melbourn, UK. · Department of Biostatistics, University Health Network, Toronto, Canada. · EORTC Headquarters, Brussels, Belgium. · Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Charité-Universitätsmedizin, Berlin. · Department of Dermatology, University Hospital, University Duisburg-Essen, Germany & German Cancer Consortium (DKTK), Heidelberg, Germany. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · Ocular Oncology Service, Department of Ophthalmology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland. · Department of Dermatology, Saarland University Medical School, Hamburg, Germany. · Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, USA. · Department of Diagnostic and Interventional Radiology, Darmstadt, Germany. · Department of Medical Oncology, Maastricht University Medical Centre, Maastricht. · Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands. · Centre Oscar Lambret, Lille, France. · Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Johann Wolfgang Goethe-University, Frankfurt, Germany. · Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada. · Oncology Unit, Azienda Ospedaliera 'Ospedali Riuniti Marche Nord', Pesaro, Italy. · University of Rennes, INSERM, Department of Ophthalmology, CHU Rennes, Rennes, France. · UPMC Hillman Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, USA. · Academic Unit of Oncology, Division of Cancer & Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK. · Division of Hematology/Oncology, Columbia University Medical Center, New York, USA. · Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney. · Melanoma Institute of Australia, Sydney, Australia. · Pubmed 31150059
2018
  • Academic Department of Clinical Oncology, Division of Cancer & Stem Cells, University of Nottingham, Nottingham, UK. · Southampton Experimental Cancer Medicine Centre and Southampton University Hospitals, Faculty of Medicine, Southampton, UK. · St James's University Hospital, Leeds, UK. · Institute of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. · Northern Institute for Cancer Research, Medical School, University of Newcastle-upon-Tyne and Wear, UK. · Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, UK. · University of Nottingham, School of Medicine Queen's Medical Centre, Nottingham, UK. · Scancell Limited, Academic Department of Clinical Oncology, University of Nottingham, Nottingham, UK. · Ichor Medical Systems, Inc., San Diego, CA, USA. · Pubmed 29872563
2015
  • Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · National Heart and Lung Institute, Imperial College, London, UK. · Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK. · Department of Pathology, University Hospitals Leuven, Leuven, Belgium. · European Organisation for Research and Treatment of Cancer (EORTC) Melanoma Group, Brussels, Belgium. · Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · School of Medicine, University of Nottingham, Nottingham, UK. · Department of Dermatology, Essen University Hospital, Essen, and German Consortium of Translational Cancer Research (DKTK), Heidelberg, Germany. · Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. · Pubmed 25871393
2014
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
2013
  • Alexander M.M. Eggermont, Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, and Université Paris-Sud, Kremlin Bicêtre, Paris, France · Stefan Suciu, Larissa Polders, and Michel Praet, European Organisation for Research and Treatment of Cancer, Brussels, Belgium · Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland · Jeremy Marsden, University Hospital Birmingham, Birmingham · Philippa Corrie, Addenbrookes Hospital, Cambridge · Poulam M. Patel, University of Nottingham, Nottingham · Neville Davidson, Broomfield Hospital, Broomfield, United Kingdom · Mario Santinami, Istituto Nazionale dei Tumori, Milan · Paolo A. Ascierto, Istituto Nazionale Tumori Fondazione Pascale, Napoli · Lorenzo Borgognoni, Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence · Maria Grazia Bernengo, University Hospital Turin, Turin, Italy · Steinar Aamdal, Oslo University Hospital and Radium Hospital, Oslo, Norway · Wim H. Kruit, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands · Lars Bastholt, Odense University Hospital, Odense, Denmark · and Alan Spatz, McGill University and Lady Davis Institute for Medical Research, Montreal, Quebec, Canada. · Pubmed 24019551
2011
  • Academic Unit of Clinical Oncology, University of Nottingham, Nottingham, United Kingdom. · Pubmed 21600759
2014
  • Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, UK. · Pubmed 24830350
2012
  • Academic Oncology, School of Molecular Medical Sciences, University of Nottingham , Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom. · Pubmed 23215743
  • Academic Oncology, University of Nottingham, School of Molecular Medical Sciences, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, UK. · Pubmed 22080065
2011
  • Translational DNA Repair Group, Laboratory of Molecular Oncology, Academic Unit of Oncology, School of Molecular Medical Sciences, Nottingham University Hospitals, University of Nottingham, Nottingham, UK. · Pubmed 21266972
Nottingham University Hospitals NHS Trust
2018
  • Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Medical Oncology, Mount Vernon Hospital, Northwood, UK. · Department of Medical Oncology, Christie Hospital, Manchester, UK. · Royal Marsden Hospital NHS Trust, London, UK. · Oncology Research, Broomfield Hospital, Chelmsford, UK. · Oncology Department, Leicester Royal Infirmary, Leicester, UK. · Sir Bobby Robson Cancer Trials Research Centre, Freeman Hospital, Newcastle upon Tyne, UK. · Leeds Cancer Centre, St James's University Hospital, Leeds, UK. · Weston Park Hospital, Academic Unit of Clinical Oncology, Sheffield, UK. · Cancer & Palliative Care, St. Helen's Hospital, St. Helens, UK. · Oncology Department, Royal Surrey County Hospital, Guildford, UK. · Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Clinical Trials Unit, Beatson WOS Cancer Centre, Glasgow, UK. · Department of Clinical Oncology, Norfolk & Norwich University Hospital, Norwich, UK. · Guy's & St. Thomas' Hospital, Guy's Cancer Centre, London, UK. · Velindre Cancer Centre, Cardiff, UK. · Exeter Oncology Centre, Royal Devon and Exeter Hospital, Exeter, UK. · St George's Hospital, Cancer Centre, London, UK. · Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK. · Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, UK. · Cancer Centre, Ninewells Hospital, Dundee, UK. · Royal Free Hospital, London, UK. · Castle Hill Hospital, Cottingham, UK. · Academic Unit of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK. · CRUK and NIHR Southampton Experimental Cancer Medicine Centre, Southampton University Hospitals NHS Foundation Trust, Southampton, UK. · Oncology Centre, Cheltenham General Hospital, Cheltenham, UK. · Oncology Department, James Cook University Hospital, Middlesbrough, UK. · Oncology Department, Poole Hospital, Dorset, UK. · Department of Oncology, University of Oxford, Oxford, UK. · Experimental Cancer Medicine Centre, Oxford, UK. · Melanoma Focus, Cambridge, UK. · Oxford NIHR Biomedical Research Centre, Oxford, UK. · Pubmed 30010756
2014
  • Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, UK. · Pubmed 24830350
2012
  • Academic Oncology, School of Molecular Medical Sciences, University of Nottingham , Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom. · Pubmed 23215743
  • Academic Oncology, University of Nottingham, School of Molecular Medical Sciences, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, UK. · Pubmed 22080065
2011
  • Translational DNA Repair Group, Laboratory of Molecular Oncology, Academic Unit of Oncology, School of Molecular Medical Sciences, Nottingham University Hospitals, University of Nottingham, Nottingham, UK. · Pubmed 21266972
Miscellaneous institutions in Brussels
2015
  • Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · National Heart and Lung Institute, Imperial College, London, UK. · Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK. · Department of Pathology, University Hospitals Leuven, Leuven, Belgium. · European Organisation for Research and Treatment of Cancer (EORTC) Melanoma Group, Brussels, Belgium. · Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · School of Medicine, University of Nottingham, Nottingham, UK. · Department of Dermatology, Essen University Hospital, Essen, and German Consortium of Translational Cancer Research (DKTK), Heidelberg, Germany. · Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. · Pubmed 25871393
5 Other Locations Show
Yearly article counts 01200232421
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.